| scholarly article | Q13442814 |
| P2093 | author name string | Didier Picard | |
| Deo Prakash Pandey | |||
| P2860 | cites work | Characterization of microRNA expression levels and their biological correlates in human cancer cell lines | Q40158414 |
| The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. | Q40168734 | ||
| The 3'-untranslated region of the human estrogen receptor alpha gene mediates rapid messenger ribonucleic acid turnover | Q40864729 | ||
| Growth inhibition by anti-estrogens and progestins in TGF-beta-resistant and -sensitive breast-tumor cells | Q41226072 | ||
| Estradiol up-regulates AUF1p45 binding to stabilizing regions within the 3'-untranslated region of estrogen receptor alpha mRNA. | Q46888895 | ||
| Regulation of the estrogen receptor in MCF-7 cells by estradiol | Q68015751 | ||
| Inefficient targeting to the endoplasmic reticulum by the signal recognition particle elicits selective defects in post-ER membrane trafficking | Q79615611 | ||
| A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 | ||
| Widespread changes in protein synthesis induced by microRNAs | Q27860886 | ||
| Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Switching from repression to activation: microRNAs can up-regulate translation | Q28131790 | ||
| MicroRNA signatures in human ovarian cancer | Q28249211 | ||
| Identification of hundreds of conserved and nonconserved human microRNAs | Q28257480 | ||
| Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network | Q28259101 | ||
| Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer | Q28261558 | ||
| Phylogenetic shadowing and computational identification of human microRNA genes | Q28302536 | ||
| The widespread impact of mammalian MicroRNAs on mRNA repression and evolution | Q29547173 | ||
| Genome-wide analysis of estrogen receptor binding sites | Q29614765 | ||
| Characterization of microRNA expression profiles in normal human tissues | Q29615492 | ||
| Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution | Q29616370 | ||
| Estrogen receptors: how do they signal and what are their targets | Q29617958 | ||
| Repression of protein synthesis by miRNAs: how many mechanisms? | Q29620361 | ||
| RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase | Q33858008 | ||
| Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters | Q33863016 | ||
| Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. | Q34712217 | ||
| miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer | Q34791023 | ||
| Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer | Q34803786 | ||
| Endocrine-responsive breast cancer and strategies for combating resistance | Q35084786 | ||
| Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis. | Q35131723 | ||
| Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation | Q35849279 | ||
| Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs | Q36053373 | ||
| Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland | Q36117022 | ||
| A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells | Q36209715 | ||
| Epigenetic information and estrogen receptor alpha expression in breast cancer | Q36364262 | ||
| Extranuclear steroid receptors: nature and actions | Q36960789 | ||
| Estrogen receptors in resistance to hormone therapy. | Q36997404 | ||
| Small is beautiful: microRNAs and breast cancer-where are we now? | Q37151040 | ||
| Proteasome-dependent degradation of the human estrogen receptor | Q37160826 | ||
| MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells | Q39913331 | ||
| Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells | Q40001498 | ||
| AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. | Q40154871 | ||
| Human MicroRNA targets | Q21563637 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| A mammalian microRNA expression atlas based on small RNA library sequencing | Q24644709 | ||
| MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer | Q24645663 | ||
| Widespread microRNA repression by Myc contributes to tumorigenesis | Q24647067 | ||
| MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1 | Q24648241 | ||
| miRBase: tools for microRNA genomics | Q24649872 | ||
| MicroRNA-373 induces expression of genes with complementary promoter sequences | Q24652547 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies | Q27497347 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| cell biology | Q7141 | ||
| P304 | page(s) | 3783-90 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA | |
| P478 | volume | 29 |
| Q55312006 | 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. |
| Q90674693 | 6-Formylindolo[3,2-b]carbazole (FICZ) Enhances The Expression of Tumor Suppressor miRNAs, miR-22, miR-515-5p, and miR-124-3p in MCF-7 Cells |
| Q42501988 | A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer |
| Q33634277 | A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer |
| Q39032003 | A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis |
| Q37056916 | Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues |
| Q38237045 | Additional stories of microRNAs. |
| Q34146968 | Altered microRNA regulation in Huntington's disease models |
| Q33533878 | An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. |
| Q34140013 | An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer |
| Q37958686 | BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype |
| Q34623204 | Characterization and differential expression of microRNAs in the ovaries of pregnant and non-pregnant goats (Capra hircus). |
| Q57092198 | Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention |
| Q43512235 | Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. |
| Q34246016 | Circulating microRNAs involved in multiple sclerosis |
| Q38339549 | Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. |
| Q51442271 | Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells. |
| Q36589361 | Derailed estrogen signaling and breast cancer: an authentic couple. |
| Q35135063 | Developmental microRNA expression profiling of murine embryonic orofacial tissue |
| Q22000752 | Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development |
| Q37682209 | Dynamics of miRNA transcriptome during gonadal development of zebrafish. |
| Q34119028 | ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches |
| Q54314330 | Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells. |
| Q37539078 | Elevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERα. |
| Q37211627 | Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review). |
| Q37962586 | Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance |
| Q24621879 | Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation |
| Q38012175 | Epigenetics of estrogen receptor-negative primary breast cancer |
| Q54974230 | Estradiol and the Development of the Cerebral Cortex: An Unexpected Role? |
| Q36661810 | Estrogen receptors and human disease: an update |
| Q34521846 | Expression of miRNAs in ovine fetal gonads: potential role in gonadal differentiation. |
| Q36838871 | Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype |
| Q54963939 | Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network. |
| Q26782613 | Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential |
| Q28816965 | Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer |
| Q28284772 | Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer |
| Q38267349 | Light-regulated microRNAs |
| Q38186042 | Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. |
| Q58718563 | Mechanisms for estrogen receptor expression in human cancer |
| Q33637461 | Meeting report: nuclear receptors: transcription factors and drug targets connecting basic research with translational medicine |
| Q28079075 | MiRNAs and miRNA Polymorphisms Modify Drug Response |
| Q35625498 | MicroRNA Expression Profile in Bovine Granulosa Cells of Preovulatory Dominant and Subordinate Follicles during the Late Follicular Phase of the Estrous Cycle. |
| Q61999299 | MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer |
| Q36618667 | MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy |
| Q60421653 | MicroRNA Regulation of Endocrine Functions in the Ovary |
| Q41885247 | MicroRNA Regulatory Networks Provide Feedback Mechanisms for Steroid Receptor Signaling |
| Q54944098 | MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management. |
| Q35811140 | MicroRNA expression profiles of bovine milk exosomes in response to Staphylococcus aureus infection |
| Q39535231 | MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development |
| Q50989062 | MicroRNA profiling in migraine without aura: pilot study. |
| Q33721789 | MicroRNA-101-mediated Akt activation and estrogen-independent growth |
| Q41136545 | MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth |
| Q37111953 | MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. |
| Q34228326 | MicroRNA-22 can reduce parathymosin expression in transdifferentiated hepatocytes |
| Q43693182 | MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein |
| Q38638014 | MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1. |
| Q40434551 | MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. |
| Q37038566 | MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress |
| Q33918344 | MicroRNA-22 regulates hypoxia signaling in colon cancer cells |
| Q47073092 | MicroRNA-22 regulates inflammation and angiogenesis via targeting VE-cadherin |
| Q30414321 | MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. |
| Q37156452 | MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. |
| Q37941371 | MicroRNA-mediated breast cancer metastasis: from primary site to distant organs |
| Q38235604 | MicroRNAs as key regulators of xenobiotic biotransformation and drug response. |
| Q36032709 | MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer |
| Q37755682 | Modulation of steroid hormone receptor activity |
| Q37588086 | Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review). |
| Q41660975 | Myeloperoxidase oxidized LDL interferes with endothelial cell motility through miR-22 and heme oxygenase 1 induction: possible involvement in reendothelialization of vascular injuries |
| Q89597721 | Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells |
| Q37605740 | Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer |
| Q37835900 | Nuclear receptors and microRNAs: Who regulates the regulators in neural stem cells? |
| Q37529397 | Oestrogen receptor negativity in breast cancer: a cause or consequence? |
| Q42755954 | Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem |
| Q37878207 | Pharmocoepigenetics: a new approach to predicting individual drug responses and targeting new drugs |
| Q39011089 | Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis. |
| Q33721926 | Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer |
| Q37802877 | Proteomics of osteoarthritic chondrocytes and cartilage |
| Q48297415 | Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives |
| Q26778413 | Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma |
| Q37710885 | Role of estrogen in hepatocellular carcinoma: is inflammation the key? |
| Q36677690 | Role of microRNAs in breast cancer |
| Q37995667 | Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants |
| Q54918383 | Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study. |
| Q48044643 | Sex-specific, reciprocal regulation of ERα and miR-22 controls muscle lipid metabolism in male mice |
| Q37811192 | Steroid receptors and microRNAs: Relationships revealed |
| Q38827031 | Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells |
| Q36562356 | TIP60-miR-22 axis as a prognostic marker of breast cancer progression |
| Q27003230 | Targeting CSC-related miRNAs for cancer therapy by natural agents |
| Q26830734 | The Akt-associated microRNAs |
| Q37210542 | The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. |
| Q37903655 | The different roles of ER subtypes in cancer biology and therapy |
| Q26822987 | The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs |
| Q37354147 | The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. |
| Q36367578 | The impact of microRNA expression on cellular proliferation |
| Q42324249 | The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147. |
| Q34408630 | The many faces of estrogen signaling. |
| Q38381678 | The novel role of miRNAs for tamoxifen resistance in human breast cancer |
| Q41098508 | The zinc-finger transcriptional factor Slug transcriptionally downregulates ERα by recruiting lysine-specific demethylase 1 in human breast cancer |
| Q37895810 | Toxicological implications of modulation of gene expression by microRNAs. |
| Q44608082 | Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. |
| Q39367785 | Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3. |
| Q35746187 | Uterine microRNA signature and consequence of their dysregulation in uterine disorders. |
| Q34117084 | Variation among rainbow trout (Oncorhynchus mykiss) estrogen receptor isoform 3' untranslated regions and the effect of 17beta-estradiol on mRNA stability in hepatocyte culture |
| Q48096559 | Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients |
| Q34517731 | miR-22 controls Irf8 mRNA abundance and murine dendritic cell development |
| Q21091130 | miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics |
| Q34225020 | miR-22 in cardiac remodeling and disease |
| Q39006097 | miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells |
| Q37536852 | miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer |
| Q34825182 | miR-22 represses cancer progression by inducing cellular senescence |
| Q36603816 | miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer |
| Q38905249 | miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer |
| Q36902949 | miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs |
| Q35946984 | miRNAs and estrogen action |
| Q35912303 | miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. |
| Q57106025 | microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy |
| Q33954625 | microRNA and cancer |
| Q38827929 | microRNA profiling in atherosclerosis, diabetes, and migraine. |
| Q24620203 | microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity |
| Q37760459 | microRNAs and EMT in mammary cells and breast cancer. |
| Q38336073 | microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer |
| Q37246198 | microRNAs in liver disease: from diagnostics to therapeutics |
Search more.